StockNews.com assumed coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a research report sent to investors on Monday. The firm issued a hold rating on the stock. TherapeuticsMD Trading Down 0.9 % TherapeuticsMD stock opened at $2.23 on Monday. The business’s 50-day simple moving average is $2.31 and its two-hundred day simple moving […]
Related Keywords
United States , Mayne Pharma , Therapeuticsmd Company Profile , Therapeuticsmd Inc , Principal Financial Group Inc , Charles Schwab Investment Management Inc , Free Report , Street Corp , Financial Group , Schwab Investment Management , Rhumbline Advisers , Get Free Report , Therapeuticsmd , Nasdaq Txmd , Txmd , Medical , Initiated Coverage , Stocknews Com ,
comparemela.com © 2020. All Rights Reserved.